相关实验视频

Updated: Jun 5, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

生物工程外体:用于帕金森病管理的细胞膜伪装生物模拟纳米载体

Maham Afzal¹, Huma Hameed¹, Ana Cláudia Paiva-Santos²

¹Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan.

European journal of pharmacology

|December 11, 2024

概括

生物工程外体显示出通过穿越血脑屏障来治疗帕金森病 (PD) 的前景. 这种方法提供了有针对性的治疗方法,有可能改善患者的治疗结果.

科学领域:

神经科学是一个神经科学.
生物技术是生物技术.
纳米医学是一种纳米医学.

背景情况:

帕金森病 (PD) 影响全球1%的60岁以上成年人.
目前的治疗方法,如深度大脑刺激和多巴胺替代,由于血脑屏障 (BBB),不能逆转PD.
BBB限制了神经系统疾病常规治疗的疗效.

研究的目的:

探索生物工程外体对治疗帕金森病的潜力.
调查外体的穿越血脑屏障 (BBB) 能力,以进行向药物输送.
评估基于外体的纳米载体,以提高PD的治疗疗效.

主要方法:

审查生物发生和生物工程外体的准备.
分析外体的自然能力,以跨越BBB.
与常规的纳米载体比较外体膜伪装的非生物纳米载体.
检查实验室试验表明改善了细胞吸收和有针对性的输送.

主要成果:

生物工程外体证明了穿越血脑屏障 (BBB) 的能力.
经过修改的外体膜伪装的非生物纳米载体显示出增强的弹性和兼容性.
实验室试验表明改善了细胞吸收和治疗有效载荷的有针对性的输送.
将非生物纳米载体与生物工程外体膜相结合,提出了一个可行的PD治疗策略.

结论:

在帕金森病治疗中,生物工程外体提供了一种有希望的策略来克服BBB.
基于外体的纳米载体促进了治疗药物的向输送,提高了治疗效率.
需要进一步的研究来解决可扩展的生产,监管批准和临床应用的长期安全性.

关键词:

生物工程生物工程的生物工程.外基因组是外基因组的组成部分.纳米载体的使用方法帕金森和帕金森的孩子们有针对性的交付目标.

更多相关视频

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...